Skip to primary navigation
Skip to main content
Skip to primary sidebar

Our Science
Our Programs
Our Team
Join Us
News & Events
Contact Us

Back to News & Media

05/21/2024

Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology

SHARE

SHARE

Privacy Policy Terms & Conditions

© Aktis Oncology 2021. All Rights Reserved.

Sign up for the latest from Aktis Oncology

Email address:

Leave this field empty if you're human: